Tammie K. Marlen

Array ( [id] => 1419983 [patent_doc_number] => 06514966 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Compounds for the treatment of obesity' [patent_app_type] => B2 [patent_app_number] => 09/754770 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39844 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514966.pdf [firstpage_image] =>[orig_patent_app_number] => 09754770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892276 [patent_doc_number] => 20010018438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands' [patent_app_type] => new [patent_app_number] => 09/754092 [patent_app_country] => US [patent_app_date] => 2001-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15713 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018438.pdf [firstpage_image] =>[orig_patent_app_number] => 09754092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1468019 [patent_doc_number] => 06458965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Aryl phenyl substituted cyclic ketoenols' [patent_app_type] => B1 [patent_app_number] => 09/646722 [patent_app_country] => US [patent_app_date] => 2001-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31895 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458965.pdf [firstpage_image] =>[orig_patent_app_number] => 09646722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653167 [patent_doc_number] => 20030008849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Acetylenic alpha -amino acid-based sulfonamide hydroxamic acid tace inhibitors' [patent_app_type] => new [patent_app_number] => 09/748912 [patent_app_country] => US [patent_app_date] => 2000-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 76655 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008849.pdf [firstpage_image] =>[orig_patent_app_number] => 09748912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6623658 [patent_doc_number] => 20020016297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => '4-oxo-2- ureido-1,4,5,6,-tetrahydro-pyrimidine derivatives' [patent_app_type] => new [patent_app_number] => 09/742753 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8741 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016297.pdf [firstpage_image] =>[orig_patent_app_number] => 09742753 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892274 [patent_doc_number] => 20010018436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Pyrimidine derivatives' [patent_app_type] => new [patent_app_number] => 09/737983 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17206 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018436.pdf [firstpage_image] =>[orig_patent_app_number] => 09737983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5859888 [patent_doc_number] => 20020123491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'SELECTIVE NEUROKININ ANTAGONISTS' [patent_app_type] => new [patent_app_number] => 09/737036 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30620 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123491.pdf [firstpage_image] =>[orig_patent_app_number] => 09737036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467990 [patent_doc_number] => 06458960 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Sulfonamide derivatives' [patent_app_type] => B1 [patent_app_number] => 09/717686 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10553 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458960.pdf [firstpage_image] =>[orig_patent_app_number] => 09717686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1601016 [patent_doc_number] => 06476023 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Aromatic heterocyclic compounds as anti-inflammatory agents' [patent_app_type] => B1 [patent_app_number] => 09/716351 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11084 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476023.pdf [firstpage_image] =>[orig_patent_app_number] => 09716351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528415 [patent_doc_number] => 06479514 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity' [patent_app_type] => B1 [patent_app_number] => 09/700682 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18216 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 892 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479514.pdf [firstpage_image] =>[orig_patent_app_number] => 09700682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384222 [patent_doc_number] => 06552025 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Diimino-piperazine derivatives for use as modulators of cell regulation' [patent_app_type] => B1 [patent_app_number] => 09/715483 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 7616 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 440 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552025.pdf [firstpage_image] =>[orig_patent_app_number] => 09715483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1248426 [patent_doc_number] => 06673784 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Electrophilic ketones for the treatment of herpesvirus infections' [patent_app_type] => B1 [patent_app_number] => 09/712002 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14141 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673784.pdf [firstpage_image] =>[orig_patent_app_number] => 09712002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645572 [patent_doc_number] => 06472397 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof' [patent_app_type] => B1 [patent_app_number] => 09/647849 [patent_app_country] => US [patent_app_date] => 2000-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17259 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472397.pdf [firstpage_image] =>[orig_patent_app_number] => 09647849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1596198 [patent_doc_number] => 06492356 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-10 [patent_title] => 'Acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/581915 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13080 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/492/06492356.pdf [firstpage_image] =>[orig_patent_app_number] => 09581915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1411724 [patent_doc_number] => 06528510 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-04 [patent_title] => 'HIV protease inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/674652 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55865 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 202 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/528/06528510.pdf [firstpage_image] =>[orig_patent_app_number] => 09674652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1450513 [patent_doc_number] => 06455525 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Heterocyclic substituted pyrazolones' [patent_app_type] => B1 [patent_app_number] => 09/702191 [patent_app_country] => US [patent_app_date] => 2000-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23842 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1316 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455525.pdf [firstpage_image] =>[orig_patent_app_number] => 09702191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561630 [patent_doc_number] => 06362182 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => 'Morpholinone and morpholine derivatives and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/702015 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23690 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1595 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362182.pdf [firstpage_image] =>[orig_patent_app_number] => 09702015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1316307 [patent_doc_number] => 06608066 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Tissue factor antagonists and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/698673 [patent_app_country] => US [patent_app_date] => 2000-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11437 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1372 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608066.pdf [firstpage_image] =>[orig_patent_app_number] => 09698673 [rel_patent_id] =>[rel_patent_doc_number] =>)